These final results, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 assist the strategy of targeting ACKR3 as a novel solution to modulate the opioid method, which could open new therapeutic avenues for opioid-related Issu